1 |
2,3-Dimercapto-1-propanesulfonic acid
| 1件: DMPS DMPS | - | - | - | 1件: 171 171 |
2 |
Acetate
| 1件: Acetate Acetate | - | - | - | 41件: 1 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 |
3 |
Bupropion
| 2件: Bupropion Bupropion; Bupropion Hydrochloride | 1件: D07591
D07591
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
4 |
Celecoxib
| 2件: Celebrex Celebrex; Celecoxib | 1件: D00567
D00567
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
5 |
Chloride ion
| 1件: Chloride Chloride | - | - | - | 28件: 6 6, 11, 13, 14, 34, 41, 46, 50, 51, 53, 60, 67, 70, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 288, 296, 297, 299, 338 |
6 |
Choline
| 1件: Choline Choline | 1件: D07690
D07690
| - | - | 4件: 93 93, 171, 193, 299 |
7 |
Copper
| 2件: Copper Copper; Nicotinamide | - | - | - | 4件: 2 2, 169, 170, 171 |
8 |
Dexmedetomidine
| 4件: Dexdor Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE | 1件: D00514
D00514
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 |
9 |
Gold
| 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 63, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 167, 171, 193, 218, 222, 224, 226, 227, 230, 271, 291, 296, 298, 310, 318 |
10 |
Interleukin-1 alpha, human recombinant
| 1件: None None | - | - | - | 18件: 6 6, 46, 51, 65, 66, 84, 85, 96, 97, 140, 161, 171, 222, 231, 246, 271, 299, 337 |
11 |
Penicillamine
| 2件: D-penicillamine D-penicillamine; PENICILLAMINE | 1件: D00496
D00496
| - | - | 2件: 51 51, 171 |
12 |
Succimer
| 1件: DMSA DMSA | 1件: D00572
D00572
| - | - | 1件: 171 171 |
13 |
Tetrathiomolybdate
| 1件: Tetrathiomolybdate Tetrathiomolybdate | - | - | - | 3件: 85 85, 93, 171 |
14 |
Triethylenetetramine
| 5件: Cufence Cufence; Cuprior; TETA; Trientine; Triethylenetetramine | - | - | - | 3件: 50 50, 58, 171 |
15 |
Zinc
| 3件: Nicotinamide Nicotinamide; Wilzin; Zinc | - | - | - | 4件: 2 2, 113, 171, 299 |
16 |
Zinc acetate
| 2件: Wilzin Wilzin; Zinc acetate | 1件: D06408
D06408
| - | - | 2件: 171 171, 299 |
17 |
Zinc gluconate
| 1件: ZINC GLUCONATE ZINC GLUCONATE | 1件: D02390
D02390
| - | - | 1件: 171 171 |